Investigating trait variability of gene co-expression network architecture in brain by controlling for genomic risk of schizophrenia
PLOS Genetics · 2023
DOI: 10.1371/journal.pgen.1010989 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, 2023. Verfasst von Eugenia Radulescu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, Maryland United States of America. Hauptthemen laut MEDLINE: Schizophrenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, NIDA NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
The effect of schizophrenia (SCZ) genetic risk on gene expression in brain remains elusive. A popular approach to this problem has been the application of gene co-expression network algorithms (e.g., WGCNA). To improve reliability with this method it is critical to remove unwanted sources of variance while also preserving biological signals of interest. In this WCGNA study of RNA-Seq data from postmortem prefrontal cortex (78 neurotypical donors, EUR ancestry), we tested the effects of SCZ genetic risk on co-expression networks. Specifically, we implemented a novel design in which gene expression was adjusted by linear regression models to preserve or remove variance explained by biological signal of interest (GWAS genomic scores for SCZ risk—(GS-SCZ), and genomic scores- GS of height (GS-Ht) as a negative control), while removing variance explained by covariates of non-interest. We calculated co-expression networks from adjusted expression (GS-SCZ and GS-Ht preserved or removed), and consensus between them (representative of a “background” network free of genomic scores effects). We then tested the overlap between GS-SCZ preserved modules and background networks reasoning that modules with reduced overlap would be most affected by GS-SCZ biology. Additionally, we tested these modules for convergence of SCZ risk (i.e., enrichment in PGC3 SCZ GWAS priority genes, enrichment in SCZ risk heritability and relevant biological ontologies. Our results highlight key aspects of GS-SCZ effects on brain co-expression networks, specifically: 1) preserving/removing SCZ genetic risk alters the co-expression modules; 2) biological pathways enriched in modules affected by GS-SCZ implicate processes of transcription, translation and metabolism that converge to influence synaptic transmission; 3) priority PGC3 SCZ GWAS genes and SCZ risk heritability are enriched in modules associated with GS-SCZ effects. Overall, our results indicate that gene co-expression networks that selectively integrate information about genetic risk can reveal novel combinations of biological pathways involved in schizophrenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, Maryland United States of America.
- Group of Psychiatric Neuroscience, Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, Bari, Italy.
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
- Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
- Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
- McKusick-Nathans Department of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
ORCID-Profile: Eugenia Radulescu
Förderung
- NIMH NIH HHS
- NIDA NIH HHS
- NIA NIH HHS
- Lieber Institute for Brain Development
Zitieren
APA
Radulescu, E., Chen, Q., Pergola, G., Di Carlo, P., Han, S., Shin, J. H., Hyde, T. M., Kleinman, J. E., & Weinberger, D. R. (2023). Investigating trait variability of gene co-expression network architecture in brain by controlling for genomic risk of schizophrenia. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1010989
Vancouver
Radulescu E, Chen Q, Pergola G, Di Carlo P, Han S, Shin JH, et al. Investigating trait variability of gene co-expression network architecture in brain by controlling for genomic risk of schizophrenia. PLOS Genetics. 2023. doi:10.1371/journal.pgen.1010989
BibTeX
@article{Radulescu2023,
author = {Radulescu, Eugenia and Chen, Qiang and Pergola, Giulio and Di Carlo, Pasquale and Han, Shizhong and Shin, Joo Heon and Hyde, Thomas M and Kleinman, Joel E and Weinberger, Daniel R},
title = {Investigating trait variability of gene co-expression network architecture in brain by controlling for genomic risk of schizophrenia},
journal = {PLOS Genetics},
year = {2023},
doi = {10.1371/journal.pgen.1010989}
}
EUVIMED